- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
PRESS RELEASE: Dr. Patricia Deverka Appointed as IVI's First Chief Science Officer
The Innovation and Value Initiative (IVI) appoints Patricia Deverka, MD, as its first Chief Science Officer.
ALEXANDRIA, Va., February 4, 2020 — The Innovation and Value Initiative (IVI), whose mission is to strengthen value assessment in healthcare that reflects its five principles of scientific rigor, transparency, patient centricity, innovation and market-based solutions, today announced that Patricia Deverka, MD, has joined the non-profit as its first Chief Science Officer. With close to 30 years of experience in the fields of health economics and outcomes research, health policy, stakeholder engagement and business development for corporations and non-profits alike, Dr. Deverka joins IVI from Geisinger National Precision Health, where she was the director for value evidence and outcomes. She is also a member of the National Human Genome Research Institute and National Advisory Council and has published on topics ranging from innovative technologies to patient engagement.
“We are excited to welcome Dr. Deverka to our team,” said Jennifer Bright, IVI’s executive director. “Her varied experience in health economics research, especially her work to meaningfully incorporate patient perspectives into clinical studies, are exactly the credentials that are needed to make a difference in the world of value assessment.”
For more on Dr. Deverka’s appointment, you can read the full press release.
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Community Oncology Reacts to Trump's Drug Pricing Executive Order
May 2nd 2025An executive order signed on Tuesday, March 15, necessitated a change in plans for this panel discussion from the 2025 Community Oncology Conference, with the assembled experts, moderated by Ted Okon, MBA, executive director of the Community Oncology Alliance, speaking to how the order would reverberate across the community oncology space.
Read More
Advancing the Art of Medicine Through Partnership
April 29th 2025Oncology leaders from Alliance Cancer Specialists, American Oncology Network, CHI St. Vincent, Memorial Sloan Kettering Cancer Center, and New York Cancer & Blood Specialists discussed the power of collaboration in cancer care, highlighting partnerships that enhance patient outcomes and resource sharing in community practices.
Read More
